Brooks Laboratories Limited (BROOKS.NS)
- Previous Close
130.97 - Open
131.00 - Bid --
- Ask --
- Day's Range
130.00 - 135.90 - 52 Week Range
73.25 - 198.86 - Volume
20,131 - Avg. Volume
67,854 - Market Cap (intraday)
3.873B - Beta (5Y Monthly) 0.73
- PE Ratio (TTM)
-- - EPS (TTM)
-6.99 - Earnings Date May 16, 2025 - May 20, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. The company offers liquid and dry powder injection, carbapenem dry powder injectables, tablets, oral suspension, dry syrup, and eye/ear drops. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
www.brookslabs.net293
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: BROOKS.NS
View MorePerformance Overview: BROOKS.NS
Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BROOKS.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BROOKS.NS
View MoreValuation Measures
Market Cap
3.77B
Enterprise Value
3.84B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.47
Price/Book (mrq)
6.52
Enterprise Value/Revenue
5.01
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-23.54%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
769.62M
Net Income Avi to Common (ttm)
-181.15M
Diluted EPS (ttm)
-6.99
Balance Sheet and Cash Flow
Total Cash (mrq)
8.08M
Total Debt/Equity (mrq)
15.18%
Levered Free Cash Flow (ttm)
--